HPV Uptake Grows Over Time
Clinical trial finds that, while multicomponent strategy did not significantly boost HPV vaccination at fixed time points, initiation rates improved steadily over time
By
Conexiant News Staff
March 3, 2026
Clinical Scorecard: HPV Uptake Grows Over Time
At a Glance
Category Detail
Condition Human Papillomavirus (HPV) Vaccination Key Mechanisms Multicomponent intervention including practice facilitation, audit and feedback, clinician education, and communication training. Target Population Pediatric patients aged 13 years and younger. Care Setting Pediatric primary care practices.
Key Highlights
HPV vaccine initiation rates improved from 80.1% to 82.0% in the intervention group over 36 months. Completion rates increased from 52.8% to 57.8% in the intervention group over the same period. Clinicians in the intervention group reported higher self-efficacy and more frequent use of announcement-style communication. Statistical significance was not achieved at individual time points but showed a significant group-by-time interaction for initiation. The intervention's effects were observed to grow over time, suggesting the need for extended evaluation periods. Guideline-Based Recommendations
Diagnosis
Management
Implement multicomponent strategies to enhance HPV vaccination rates. Monitoring & Follow-up
Regular audit and feedback of vaccination rates should be conducted. Risks
COVID-19 pandemic disrupted early implementation, affecting the intervention's rollout. Patient & Prescribing Data
Pediatric patients in the St Louis, Missouri metropolitan area.
Sustained system-level support is crucial for improving HPV vaccination coverage.
Clinical Best Practices
Embed structured facilitation and feedback into vaccination workflows. Provide ongoing training in communication strategies for clinicians. References
